News brief
On 2026-04-10, according to Xiniu Data, Anda Biotechnology completed equity financing for an undisclosed amount. The investor was Gongqingcheng Kunyuan Investment Partnership (Limited Partnership). The company develops personalized tumor neoantigen vaccines.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年4月10日，据烯牛数据报道，安达生物完成股权投资融资，金额未披露。投资方为共青城坤元投资合伙企业（有限合伙）。该公司为个性化肿瘤新抗原疫苗研发商。